{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:22:12Z","timestamp":1778934132707,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2008,10,31]],"date-time":"2008-10-31T00:00:00Z","timestamp":1225411200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s00198-008-0780-2","type":"journal-article","created":{"date-parts":[[2008,10,30]],"date-time":"2008-10-30T11:05:51Z","timestamp":1225364751000},"page":"1167-1173","source":"Crossref","is-referenced-by-count":57,"title":["Relation between fibroblast growth factor-23, body weight and bone mineral density in elderly men"],"prefix":"10.1007","volume":"20","author":[{"given":"R.","family":"Marsell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A. I.","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Mallmin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Mellstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Orwoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ohlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. B.","family":"Jonsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6.","family":"Ljunggren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. E.","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,10,31]]},"reference":[{"issue":"11","key":"780_CR1","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","volume":"98","author":"T Shimada","year":"2001","unstructured":"Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T (2001) Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98(11):6500\u20136505","journal-title":"Proc Natl Acad Sci USA"},{"key":"780_CR2","first-page":"434","volume":"4","author":"EA Imel","year":"2007","unstructured":"Imel EA, Econs MJ (2007) Fibrous dysplasia, phosphate wasting and fibroblast growth factor 23. Pediatr Endocrinol Rev 4 Suppl 4:434\u2013439","journal-title":"Pediatr Endocrinol Rev 4 Suppl"},{"issue":"4","key":"780_CR3","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1210\/jc.2004-2238","volume":"90","author":"T Larsson","year":"2005","unstructured":"Larsson T, Yu X, Davis SI, Draman MS, Mooney SD, Cullen MJ, White KE (2005) A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis. J Clin Endocrinol Metab 90(4):2424\u20132427","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"780_CR4","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","volume":"64","author":"T Larsson","year":"2003","unstructured":"Larsson T, Nisbeth U, Ljunggren O, Juppner H, Jonsson KB (2003) Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 64(6):2272\u20132279","journal-title":"Kidney Int"},{"issue":"9","key":"780_CR5","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1210\/jc.2004-0724","volume":"89","author":"A Gupta","year":"2004","unstructured":"Gupta A, Winer K, Econs MJ, Marx SJ, Collins MT (2004) FGF-23 is elevated by chronic hyperphosphatemia. J Clin Endocrinol Metab 89(9):4489\u20134492","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"780_CR6","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","volume":"112","author":"M Riminucci","year":"2003","unstructured":"Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, Waguespack S, Gupta A, Hannon T, Econs MJ, Bianco P, Gehron Robey P (2003) FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 112(5):683\u2013692","journal-title":"J Clin Invest"},{"issue":"39","key":"780_CR7","doi-asserted-by":"crossref","first-page":"37419","DOI":"10.1074\/jbc.M304544200","volume":"278","author":"S Liu","year":"2003","unstructured":"Liu S, Guo R, Simpson LG, Xiao ZS, Burnham CE, Quarles LD (2003) Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem 278(39):37419\u201337426","journal-title":"J Biol Chem"},{"issue":"4","key":"780_CR8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","volume":"113","author":"T Shimada","year":"2004","unstructured":"Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T (2004) Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113(4):561\u2013568","journal-title":"J Clin Invest"},{"issue":"6","key":"780_CR9","doi-asserted-by":"crossref","first-page":"E1101","DOI":"10.1152\/ajpendo.00502.2004","volume":"288","author":"M Ito","year":"2005","unstructured":"Ito M, Sakai Y, Furumoto M, Segawa H, Haito S, Yamanaka S, Nakamura R, Kuwahata M, Miyamoto K (2005) Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells. Am J Physiol Endocrinol Metab 288(6):E1101\u2013E1109","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"7","key":"780_CR10","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1210\/en.2003-1768","volume":"145","author":"T Larsson","year":"2004","unstructured":"Larsson T, Marsell R, Schipani E, Ohlsson C, Ljunggren O, Tenenhouse HS, Juppner H, Jonsson KB (2004) Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. Endocrinology 145(7):3087\u20133094","journal-title":"Endocrinology"},{"issue":"7120","key":"780_CR11","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","volume":"444","author":"I Urakawa","year":"2006","unstructured":"Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, Fujita T, Fukumoto S, Yamashita T (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444(7120):770\u2013774","journal-title":"Nature"},{"key":"780_CR12","doi-asserted-by":"crossref","unstructured":"Wang H, Yoshiko Y, Yamamoto R, Minamizaki T, Kozai K, Tanne K, Aubin JE, Maeda N (2008) Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro. J Bone Miner Res 23(6):939\u2013948 Jun","DOI":"10.1359\/jbmr.080220"},{"issue":"6655","key":"780_CR13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","volume":"390","author":"M Kuro-o","year":"1997","unstructured":"Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390(6655):45\u201351","journal-title":"Nature"},{"issue":"3","key":"780_CR14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1210\/er.2005-0019","volume":"27","author":"KE White","year":"2006","unstructured":"White KE, Larsson TM, Econs MJ (2006) The roles of specific genes implicated as circulating factors involved in normal and disordered phosphate homeostasis: Frp-4, MEPE, and FGF23. Endocr Rev 27(3):221\u2013241","journal-title":"Endocr Rev"},{"issue":"4","key":"780_CR15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1359\/jbmr.060110","volume":"21","author":"D Mellstrom","year":"2006","unstructured":"Mellstrom D, Johnell O, Ljunggren O, Eriksson AL, Lorentzon M, Mallmin H, Holmberg A, Redlund-Johnell I, Orwoll E, Ohlsson C (2006) Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J Bone Miner Res 21(4):529\u2013535","journal-title":"J Bone Miner Res"},{"issue":"6","key":"780_CR16","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s001980170087","volume":"12","author":"Y Lu","year":"2001","unstructured":"Lu Y, Fuerst T, Hui S, Genant HK (2001) Standardization of bone mineral density at femoral neck, trochanter and Ward\u2019s triangle. Osteoporos Int 12(6):438\u2013444","journal-title":"Osteoporos Int"},{"issue":"10","key":"780_CR17","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/jbmr.5650091002","volume":"9","author":"HK Genant","year":"1994","unstructured":"Genant HK, Grampp S, Gluer CC, Faulkner KG, Jergas M, Engelke K, Hagiwara S, Van Kuijk C (1994) Universal standardization for dual X-ray absorptiometry: patient and phantom cross-calibration results. J Bone Miner Res 9(10):1503\u20131514","journal-title":"J Bone Miner Res"},{"issue":"5","key":"780_CR18","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s001980050039","volume":"7","author":"J Hanson","year":"1997","unstructured":"Hanson J (1997) Standardization of proximal femur BMD measurements. International Committee for Standards in Bone Measurement. Osteoporos Int 7(5):500\u2013501","journal-title":"Osteoporos Int"},{"issue":"11","key":"780_CR19","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","volume":"87","author":"Y Yamazaki","year":"2002","unstructured":"Yamazaki Y, Okazaki R, Shibata M, Hasegawa Y, Satoh K, Tajima T, Takeuchi Y, Fujita T, Nakahara K, Yamashita T, Fukumoto S (2002) Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia. J Clin Endocrinol Metab 87(11):4957\u20134960","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"780_CR20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1530\/EJE-07-0534","volume":"158","author":"R Marsell","year":"2008","unstructured":"Marsell R, Grundberg E, Krajisnik T, Mallmin H, Karlsson M, Mellstrom D, Orwoll E, Ohlsson C, Jonsson KB, Ljunggren O, Larsson TE (2008) Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men. Eur J Endocrinol 158(1):125\u2013129","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"780_CR21","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1080\/00365510601187773","volume":"67","author":"M Flodin","year":"2007","unstructured":"Flodin M, Jonsson AS, Hansson LO, Danielsson LA, Larsson A (2007) Evaluation of Gentian cystatin C reagent on Abbott Ci8200 and calculation of glomerular filtration rate expressed in mL\/min\/1.73\u00a0m(2) from the cystatin C values in mg\/L. Scand J Clin Lab Invest 67(5):560\u2013567","journal-title":"Scand J Clin Lab Invest"},{"issue":"17","key":"780_CR22","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","volume":"348","author":"KB Jonsson","year":"2003","unstructured":"Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Juppner H (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348(17):1656\u20131663","journal-title":"N Engl J Med"},{"issue":"1","key":"780_CR23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/sj.ki.5002622","volume":"73","author":"P Urena Torres","year":"2008","unstructured":"Urena Torres P, Friedlander G, de Vernejoul MC, Silve C, Prie D (2008) Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients. Kidney Int 73(1):102\u2013107","journal-title":"Kidney Int"},{"key":"780_CR24","doi-asserted-by":"crossref","unstructured":"Masuyama R, Stockmans I, Torrekens S, Van Looveren R, Maes C, Carmeliet P, Bouillon R, Carmeliet G (2006) Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. J Clin Invest 116(12):3150\u20133159 Dec","DOI":"10.1172\/JCI29463"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-008-0780-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-008-0780-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-008-0780-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T19:01:00Z","timestamp":1558638060000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-008-0780-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,31]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["780"],"URL":"https:\/\/doi.org\/10.1007\/s00198-008-0780-2","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,31]]}}}